Cargando…
Immunoreactive insulin stability in horses at risk of insulin dysregulation
BACKGROUND: Diseases associated with insulin dysregulation (ID), such as equine metabolic syndrome and pituitary pars intermedia dysfunction, are of interest to practitioners because of their association with laminitis. Accurate insulin concentration assessment is critical in diagnosing and managing...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872612/ https://www.ncbi.nlm.nih.gov/pubmed/31617618 http://dx.doi.org/10.1111/jvim.15629 |
_version_ | 1783472522752163840 |
---|---|
author | Leschke, Dakota H. Muir, Genevieve S. Hodgson, Jack K. Coyle, Mitchell Horn, Remona Bertin, François‐René |
author_facet | Leschke, Dakota H. Muir, Genevieve S. Hodgson, Jack K. Coyle, Mitchell Horn, Remona Bertin, François‐René |
author_sort | Leschke, Dakota H. |
collection | PubMed |
description | BACKGROUND: Diseases associated with insulin dysregulation (ID), such as equine metabolic syndrome and pituitary pars intermedia dysfunction, are of interest to practitioners because of their association with laminitis. Accurate insulin concentration assessment is critical in diagnosing and managing these diseases. HYPOTHESIS/OBJECTIVES: To determine the effect of time, temperature, and collection tube type on insulin concentrations in horses at risk of ID. ANIMALS: Eight adult horses with body condition score >6/9. METHODS: In this prospective study, subjects underwent an infeed oral glucose test 2 hours before blood collection. Blood samples were divided into ethylenediaminetetraacetic acid, heparinized, or serum tubes and stored at 4 or 20°C. Tubes were centrifuged and analyzed for insulin by a chemiluminescent assay over 8 days. Changes in insulin concentrations were compared with a linear mixed effects model. RESULTS: An overall effect of time, tube type and temperature was identified (P = .01, P = 0.001, and P = 0.001, respectively). Serum and heparinized samples had similar concentrations for 3 days at 20°C and 8 days at 4°C; however, after 3 days at 20°C, heparinized samples had significantly higher insulin concentrations (P = .004, P = .03, and P = .03 on consecutive days). Ethylenediaminetetraacetic acid samples had significantly lower insulin concentrations regardless of time and temperature (P = .001 for all comparisons). CONCLUSIONS AND CLINICAL IMPORTANCE: These results suggest an ideal protocol to determine insulin concentrations involves using serum or heparinized samples with analysis occurring within 3 days at 20°C or 8 days at 4°C. |
format | Online Article Text |
id | pubmed-6872612 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68726122019-11-25 Immunoreactive insulin stability in horses at risk of insulin dysregulation Leschke, Dakota H. Muir, Genevieve S. Hodgson, Jack K. Coyle, Mitchell Horn, Remona Bertin, François‐René J Vet Intern Med EQUID BACKGROUND: Diseases associated with insulin dysregulation (ID), such as equine metabolic syndrome and pituitary pars intermedia dysfunction, are of interest to practitioners because of their association with laminitis. Accurate insulin concentration assessment is critical in diagnosing and managing these diseases. HYPOTHESIS/OBJECTIVES: To determine the effect of time, temperature, and collection tube type on insulin concentrations in horses at risk of ID. ANIMALS: Eight adult horses with body condition score >6/9. METHODS: In this prospective study, subjects underwent an infeed oral glucose test 2 hours before blood collection. Blood samples were divided into ethylenediaminetetraacetic acid, heparinized, or serum tubes and stored at 4 or 20°C. Tubes were centrifuged and analyzed for insulin by a chemiluminescent assay over 8 days. Changes in insulin concentrations were compared with a linear mixed effects model. RESULTS: An overall effect of time, tube type and temperature was identified (P = .01, P = 0.001, and P = 0.001, respectively). Serum and heparinized samples had similar concentrations for 3 days at 20°C and 8 days at 4°C; however, after 3 days at 20°C, heparinized samples had significantly higher insulin concentrations (P = .004, P = .03, and P = .03 on consecutive days). Ethylenediaminetetraacetic acid samples had significantly lower insulin concentrations regardless of time and temperature (P = .001 for all comparisons). CONCLUSIONS AND CLINICAL IMPORTANCE: These results suggest an ideal protocol to determine insulin concentrations involves using serum or heparinized samples with analysis occurring within 3 days at 20°C or 8 days at 4°C. John Wiley & Sons, Inc. 2019-10-16 2019 /pmc/articles/PMC6872612/ /pubmed/31617618 http://dx.doi.org/10.1111/jvim.15629 Text en © 2019 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | EQUID Leschke, Dakota H. Muir, Genevieve S. Hodgson, Jack K. Coyle, Mitchell Horn, Remona Bertin, François‐René Immunoreactive insulin stability in horses at risk of insulin dysregulation |
title | Immunoreactive insulin stability in horses at risk of insulin dysregulation |
title_full | Immunoreactive insulin stability in horses at risk of insulin dysregulation |
title_fullStr | Immunoreactive insulin stability in horses at risk of insulin dysregulation |
title_full_unstemmed | Immunoreactive insulin stability in horses at risk of insulin dysregulation |
title_short | Immunoreactive insulin stability in horses at risk of insulin dysregulation |
title_sort | immunoreactive insulin stability in horses at risk of insulin dysregulation |
topic | EQUID |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872612/ https://www.ncbi.nlm.nih.gov/pubmed/31617618 http://dx.doi.org/10.1111/jvim.15629 |
work_keys_str_mv | AT leschkedakotah immunoreactiveinsulinstabilityinhorsesatriskofinsulindysregulation AT muirgenevieves immunoreactiveinsulinstabilityinhorsesatriskofinsulindysregulation AT hodgsonjackk immunoreactiveinsulinstabilityinhorsesatriskofinsulindysregulation AT coylemitchell immunoreactiveinsulinstabilityinhorsesatriskofinsulindysregulation AT hornremona immunoreactiveinsulinstabilityinhorsesatriskofinsulindysregulation AT bertinfrancoisrene immunoreactiveinsulinstabilityinhorsesatriskofinsulindysregulation |